ENTITY

Access Bio Inc (950130 KS)

Analysis

Health Care • South Korea

Access Bio Inc. develops, manufactures, and markets in-vitro diagnostic (IVD) tests. The Company develops rapid diagnostic test (RDT) for Malaria and Pregnancy.

Refresh

Focused

No publications yet

There aren’t any broker reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00